The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease

Young Suk Lim, W. Ray Kim

Research output: Contribution to journalArticle

169 Citations (Scopus)

Abstract

Hepatic fibrosis is an integral part in the progression of chronic liver disease, ultimately leading to cirrhosis and hepatocellular carcinoma. Globally, alcohol consumption, hepatitis B (HBV) and hepatitis C (HCV) have been the main causes of cirrhosis. More recently, the increasing prevalence of obesity and the metabolic syndrome has resulted in increasing incidence of cirrhosis secondary to nonalcoholic fatty liver disease (NAFLD), especially in developed countries. Chronic liver disease and cirrhosis are important causes of morbidity and mortality in the world. Moreover, the burden of chronic liver disease is projected to increase, due in part to the increasing prevalence of end-stage liver disease and HCC secondary to NAFLD and HCV.

Original languageEnglish (US)
Pages (from-to)733-746
Number of pages14
JournalClinics in Liver Disease
Volume12
Issue number4
DOIs
StatePublished - Nov 2008

Fingerprint

End Stage Liver Disease
Fibrosis
Liver Diseases
Chronic Disease
Liver
Hepatitis C
Hepatitis B
Developed Countries
Alcohol Drinking
Liver Cirrhosis
Hepatocellular Carcinoma
Obesity
Morbidity
Mortality
Incidence
Non-alcoholic Fatty Liver Disease

Keywords

  • Cirrhosis
  • End-stage liver disease
  • Epidemiology
  • Global impact
  • Hepatic fibrosis

ASJC Scopus subject areas

  • Hepatology

Cite this

The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease. / Lim, Young Suk; Kim, W. Ray.

In: Clinics in Liver Disease, Vol. 12, No. 4, 11.2008, p. 733-746.

Research output: Contribution to journalArticle

Lim, Young Suk ; Kim, W. Ray. / The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease. In: Clinics in Liver Disease. 2008 ; Vol. 12, No. 4. pp. 733-746.
@article{f4adfcb84d734bec93c9375c542ec1d0,
title = "The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease",
abstract = "Hepatic fibrosis is an integral part in the progression of chronic liver disease, ultimately leading to cirrhosis and hepatocellular carcinoma. Globally, alcohol consumption, hepatitis B (HBV) and hepatitis C (HCV) have been the main causes of cirrhosis. More recently, the increasing prevalence of obesity and the metabolic syndrome has resulted in increasing incidence of cirrhosis secondary to nonalcoholic fatty liver disease (NAFLD), especially in developed countries. Chronic liver disease and cirrhosis are important causes of morbidity and mortality in the world. Moreover, the burden of chronic liver disease is projected to increase, due in part to the increasing prevalence of end-stage liver disease and HCC secondary to NAFLD and HCV.",
keywords = "Cirrhosis, End-stage liver disease, Epidemiology, Global impact, Hepatic fibrosis",
author = "Lim, {Young Suk} and Kim, {W. Ray}",
year = "2008",
month = "11",
doi = "10.1016/j.cld.2008.07.007",
language = "English (US)",
volume = "12",
pages = "733--746",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease

AU - Lim, Young Suk

AU - Kim, W. Ray

PY - 2008/11

Y1 - 2008/11

N2 - Hepatic fibrosis is an integral part in the progression of chronic liver disease, ultimately leading to cirrhosis and hepatocellular carcinoma. Globally, alcohol consumption, hepatitis B (HBV) and hepatitis C (HCV) have been the main causes of cirrhosis. More recently, the increasing prevalence of obesity and the metabolic syndrome has resulted in increasing incidence of cirrhosis secondary to nonalcoholic fatty liver disease (NAFLD), especially in developed countries. Chronic liver disease and cirrhosis are important causes of morbidity and mortality in the world. Moreover, the burden of chronic liver disease is projected to increase, due in part to the increasing prevalence of end-stage liver disease and HCC secondary to NAFLD and HCV.

AB - Hepatic fibrosis is an integral part in the progression of chronic liver disease, ultimately leading to cirrhosis and hepatocellular carcinoma. Globally, alcohol consumption, hepatitis B (HBV) and hepatitis C (HCV) have been the main causes of cirrhosis. More recently, the increasing prevalence of obesity and the metabolic syndrome has resulted in increasing incidence of cirrhosis secondary to nonalcoholic fatty liver disease (NAFLD), especially in developed countries. Chronic liver disease and cirrhosis are important causes of morbidity and mortality in the world. Moreover, the burden of chronic liver disease is projected to increase, due in part to the increasing prevalence of end-stage liver disease and HCC secondary to NAFLD and HCV.

KW - Cirrhosis

KW - End-stage liver disease

KW - Epidemiology

KW - Global impact

KW - Hepatic fibrosis

UR - http://www.scopus.com/inward/record.url?scp=54549119175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54549119175&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2008.07.007

DO - 10.1016/j.cld.2008.07.007

M3 - Article

VL - 12

SP - 733

EP - 746

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 4

ER -